TD Cowen cuts ICON stock price target to $254, maintains Buy rating
TD Cowen adjusted its financial outlook for ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries.
Wall Street Journal5d
Icon Energy Corp.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Icon (ICLR) Receives a Buy from RBC Capital
RBC Capital analyst Sean Dodge maintained a Buy rating on Icon (ICLR – Research Report) yesterday and set a price target of $263.00. The ...
Icon (ICLR) Gets a Buy from Evercore ISI
In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Buy rating on Icon (ICLR – Research Report), with a price ...
Wall Street Journal18d
Icon Group Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...